$-0.04 EPS Expected for Corindus Vascular Robotics, Inc. (CVRS)

Analysts expect Corindus Vascular Robotics, Inc. (NYSEAMERICAN:CVRS) to report $-0.04 EPS on March, 13.They anticipate $0.00 EPS change or 0.00 % from last quarter’s $-0.04 EPS. After having $-0.04 EPS previously, Corindus Vascular Robotics, Inc.’s analysts see 0.00 % EPS growth. The stock increased 1.40% or $0.03 during the last trading session, reaching $1.46. About 52,770 shares traded. Corindus Vascular Robotics, Inc. (NYSEAMERICAN:CVRS) has risen 50.50% since March 6, 2018 and is uptrending. It has outperformed by 46.13% the S&P500.

Corindus Vascular Robotics, Inc. designs, makes, and sells robotic-assisted precision vascular intervention systems for use in interventional vascular procedures. The company has market cap of $279.33 million. The firm offers CorPath system, a medical device with robotic-assisted precision for radial, coronary, and peripheral procedures. It currently has negative earnings. The Company’s CorPath system facilitates stent positioning for PCI procedures by allowing a physician to measure, manipulate, and advance devices with robotic precision; and CorPath GRX system enables the precise, robotic-assisted control of coronary guide catheters, guidewires, and balloon/stent devices from the safety of a radiation-shielded interventional cockpit.

More notable recent Corindus Vascular Robotics, Inc. (NYSEAMERICAN:CVRS) news were published by: Businesswire.com which released: “Corindus to Present at Canaccord Genuity 38th Annual Growth Conference – Business Wire” on August 03, 2018, also Businesswire.com with their article: “James R. Tobin Joins Corindus Board of Directors – Business Wire” published on March 13, 2018, Businesswire.com published: “Corindus Announces Pharmaceutical and Medical Device Agency (PMDA) Approval of CorPath GRX System in Japan – Business Wire” on June 08, 2018. More interesting news about Corindus Vascular Robotics, Inc. (NYSEAMERICAN:CVRS) were released by: Businesswire.com and their article: “Corindus to Showcase CorPath GRX® System for Peripheral Vascular Interventions at the 2018 Amputation Prevention Symposium – Business Wire” published on August 06, 2018 as well as Businesswire.com‘s news article titled: “Corindus Announces First Live Transmission of Remote Robotic Demonstration Performed at Transcatheter Cardiovascular Therapeutics 2018 Conference – Business Wire” with publication date: September 24, 2018.

Receive News & Ratings Via Email – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings with our FREE daily email newsletter.